Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yingkerui Innovative Drug Research is a prominent Chinese pharmaceutical R&D company specializing in the modernization of Traditional Chinese Medicine (TCM) and the development of innovative drug delivery systems. As a core subsidiary of the Yingkerui Pharmaceutical Group, the company focuses on high-end formulations, particularly nebulized inhalations, ophthalmic preparations, and transdermal delivery systems for respiratory and sensory organ diseases. Yingkerui operates a comprehensive R&D model, providing services ranging from drug discovery and pharmacodynamics to clinical trial coordination and regulatory registration. The company is widely recognized for its proprietary technology platforms that integrate traditional therapeutic principles with modern inhalation and nanotechnology to improve drug efficacy and patient compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Yingkerui Innovative Drug Research.